Published 03-13-09
Submitted by Bayer
PITTSBURGH,PA. - March 13, 2009 - Bayer Corporation has been named one of DiversityInc's Top 10 Companies for Global Diversity, a select list of companies with strong commitments to creating a diverse and inclusive global culture.
DiversityInc, launched in 1997, publishes a monthly business magazine and daily news Web site focusing on diversity in the workplace.
This is the first time Bayer has been included on the list. The other nine companies listed are Accenture, Cisco Systems, Colgate-Palmolive, Deloitte & Touche, IBM Corporation, Novartis Pharmaceuticals, PepsiCo, PricewaterhouseCoopers and Procter & Gamble.
"We are proud to be among the top companies selected by DiversityInc. As a global enterprise, Bayer needs to understand a complex combination of domestic and foreign customers, markets and customs. We need to apply dynamic teamwork to big challenges and the more perspectives, the better," said Greg Babe, President and CEO of Bayer Corporation and Bayer MaterialScience LLC. "Bayer's proving that diversity allows us to improve ourselves and those around us. It increases our productivity, our ability to be innovative and our human potential."
The DiversityInc evaluators commended Bayer for its diversity philosophy and initiatives, including:
About DiversityInc
With a monthly business magazine and a daily news Web site, DiversityInc is the leading print and online news source covering corporate diversity. DiversityInc was launched in 1997. Please visit www.DiversityInc.com for more information.
About Bayer Corporation
Bayer Corporation, headquartered in Pittsburgh, is a subsidiary of Bayer AG, an international health care, nutrition and high-tech materials group based in Leverkusen, Germany. In North America, Bayer had 2008 net sales of 8 billion euros (about $12 billion) and employed 17,000 at year end. Bayer's three subgroups, Bayer HealthCare, Bayer CropScience and Bayer MaterialScience, improve people's lives through a broad range of essential products that help diagnose, prevent and treat diseases; protect crops and enhance yields; and advance automobile safety and durability.
Forward-Looking Statements"¨This news release contains forward-looking statements based on current assumptions and forecasts made by Bayer Group management. Various known and unknown risks, uncertainties and other factors could lead to material differences between the actual future results, financial situation, development or performance of the company and the estimates given here. These factors include those discussed in our annual and interim reports filed with the Frankfurt Stock Exchange. The company assumes no liability whatsoever to update these forward-looking statements or to conform them to future events or developments.
Bayer: Science For A Better Life
Bayer is a global enterprise with core competencies in the Life Science fields of health care and agriculture. Its products and services are designed to benefit people and improve their quality of life. At the same time, the Group aims to create value through innovation, growth and high earning power. Bayer is committed to the principles of sustainable development and to its social and ethical responsibilities as a corporate citizen. In fiscal 2015, the Group employed around 117,000 people and had sales of EUR 46.3 billion. Capital expenditures amounted to EUR 2.6 billion, R&D expenses to EUR 4.3billion. These figures include those for the high-tech polymers business, which was floated on the stock market as an independent company named Covestro on October 6, 2015. For more information, go to www.bayer.com.
More from Bayer